Does the internal thoracic artery graft delay the recovery of myocardial metabolism?

V Rao1, G T Christakis, R D Weisel

  • 1Division of Cardiovascular Surgery, Toronto Hospital, Ontario, Canada.

Insights

The left internal thoracic artery (LITA) graft offers comparable myocardial protection to saphenous vein grafts during coronary artery bypass grafting. Advances in cardioplegia ensure similar high-energy phosphate levels, supporting LITA graft use.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Metabolism
  • Myocardial Protection

Background:

  • Left internal thoracic artery (LITA) grafts show superior long-term patency compared to saphenous vein grafts for the left anterior descending artery.
  • Surgeons' reluctance to use LITA grafts stems from concerns about delivering cardioplegia to the left anterior descending artery territory.

Purpose of the Study:

  • To compare myocardial high-energy phosphate levels and metabolites between LITA and saphenous vein grafts to the left anterior descending artery.
  • To assess the impact of LITA graft use on myocardial protection during coronary artery bypass grafting.

Main Methods:

  • Prospective comparison of myocardial high-energy phosphates and metabolites in patients receiving LITA versus saphenous vein grafts.
  • Obtained right and left ventricular biopsy specimens at three time points: pre-cross-clamping, post-cross-clamp removal, and 10 minutes post-reperfusion.

Main Results:

  • No significant differences in right ventricular metabolites between LITA and saphenous vein graft groups.
  • Improved myocardial protection observed over time, with a higher proportion of LITA graft patients in the later period (80% vs. 63%).
  • Patients receiving LITA grafts with cold antegrade cardioplegia demonstrated better preservation of myocardial high-energy phosphates.

Conclusions:

  • Modern myocardial protection strategies effectively preserve high-energy phosphate levels post-cardioplegic arrest.
  • LITA graft utilization in elective coronary artery bypass grafting does not negatively impact myocardial metabolism.
  • Further research is needed to evaluate LITA graft use in urgent or emergent cardiac procedures.
Abstract

Related Concept Videos